ResMed (RMD) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.95 -0.5%
EPS Growth %: +5.5%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
IMPP, RH, YB, More
EPS Growth %: +5.5%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
IMPP, RH, YB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Goldman Sachs Upgrades National Australia Bank Ltd. (NAB:AU) (NABZY) to Neutral
- Academy Sports surges on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
